StockFacets
About
Sign-up
Sign-in
Earnings Calendar
Prices are updated after-hours
Published
Previous years
30
Publishing Date
2021 - 10 - 01
27
2021 - 09 - 30
3
Sector
Commercial services
2
Finance
1
Health technology
23
Manufacturing
2
Tags
Acquisition
18
Acquisitions
2
Antibody
2
Application
3
Authorized
2
Automotive
3
Awards
4
Biocanada
3
Biocapital
2
Biopharma
2
Bioscience
4
Biosimilar
2
Biotech-bay
6
Biotechnology
5
Blood
3
Brands
2
Breast cancer
2
Cancer
30
Car-t
2
Communication
3
Communications
3
Conference
26
Contract
3
Covid
6
Distribution
7
Drug
3
Energy
6
Europe
3
Events
7
Financial results
7
Genetown
4
Grant
9
Granted
9
Growth
13
Immunotherapy
22
Iot
5
Liver
6
Molecular
5
N/a
292
Oda
3
Offering
9
Pharm-country
4
Phase 1
5
Phase 2
6
Phase 2b
5
Positive
3
Pre-clinical
9
Preclinical
9
Presentation
16
Program
3
Research
14
Restaurant
3
Results
15
Sales
3
Solid tumors
3
Technology
6
Test
3
Therapy
24
Treatment
4
Trial
10
Entities
Actinium pharmaceuticals, inc.
1
Affimed n.v.
1
Alx oncology holdings inc.
1
Amgen inc.
1
Anixa biosciences, inc.
1
Aravive, inc.
1
Atreca, inc.
1
Atyr pharma, inc.
1
Bicycle therapeutics plc
1
Biontech se
2
Celyad sa
1
Crispr therapeutics ag
1
Fate therapeutics, inc.
1
Genmab a/s
1
Hologic, inc.
1
Ikena oncology inc
1
Immuneering corp class a
1
Imv inc.
2
Iovance biotherapeutics, inc.
1
Nextcure, inc.
1
Oncorus, inc.
1
Poseida therapeutics, inc.
1
Repare therapeutics inc.
1
Replimune group, inc.
1
Salarius pharmaceuticals, inc.
1
Sanofi
1
Sensei biotherapeutics inc
1
Shattuck labs, inc.
1
Tanger factory outlet centers, inc.
1
Tempest therapeutics inc
1
Symbols
AFMD
1
ALXO
1
AMGN
1
ANIX
1
ARAV
1
ATNM
1
BCEL
1
BCYC
1
BNTX
2
CRSP
1
CYAD
1
FATE
1
GMAB
1
GNMSF
1
HOLX
1
IKNA
1
IMRX
1
IMV
2
IOVA
1
LIFE
1
NXTC
1
ONCR
1
PSTX
1
REPL
1
RPTX
1
SKT
1
SLRX
1
SNSE
1
SNY
1
SNYNF
1
STTK
1
TPST
1
Exchanges
Amex
1
Nasdaq
28
Nyse
1
Crawled Date
2024 - 04 - 09
16
2024 - 04 - 08
15
2024 - 03 - 06
13
2024 - 03 - 05
23
2023 - 12 - 06
12
2023 - 11 - 28
11
2023 - 11 - 06
11
2023 - 11 - 03
19
2023 - 10 - 31
11
2023 - 10 - 23
19
2023 - 10 - 04
16
2023 - 10 - 03
13
2023 - 09 - 27
17
2023 - 09 - 11
12
2023 - 05 - 25
14
2023 - 04 - 19
12
2023 - 04 - 18
17
2023 - 04 - 17
17
2023 - 03 - 15
17
2023 - 03 - 14
25
2022 - 12 - 08
17
2022 - 12 - 01
11
2022 - 11 - 10
18
2022 - 10 - 12
11
2022 - 10 - 06
12
2022 - 10 - 05
18
2022 - 09 - 12
13
2022 - 06 - 06
11
2022 - 04 - 08
27
2022 - 03 - 09
13
2022 - 03 - 08
32
2022 - 03 - 07
12
2022 - 01 - 19
14
2022 - 01 - 18
11
2021 - 12 - 10
19
2021 - 12 - 09
13
2021 - 11 - 30
12
2021 - 11 - 12
16
2021 - 11 - 09
12
2021 - 10 - 28
11
2021 - 10 - 25
11
2021 - 10 - 13
10
2021 - 10 - 07
19
2021 - 10 - 04
10
2021 - 10 - 01
30
2021 - 09 - 30
11
2021 - 09 - 20
13
2021 - 09 - 14
10
2021 - 06 - 04
12
2021 - 06 - 03
11
2021 - 05 - 21
10
2021 - 05 - 20
13
2021 - 04 - 12
16
2021 - 04 - 10
15
2021 - 04 - 09
15
2021 - 04 - 08
10
2021 - 03 - 21
11
2021 - 03 - 10
16
2020 - 12 - 09
13
2020 - 12 - 01
20
Crawled Time
00:00
3
07:00
1
10:00
1
12:00
1
12:15
8
13:00
2
13:15
1
14:00
6
14:15
5
15:00
1
16:00
1
Source
salariuspharma.com
1
www.biospace.com
16
www.celyad.com
1
www.globenewswire.com
8
www.prnewswire.com
4
Sort by:
after hours % change
|
delayed % change
|
gain open
|
gain high
|
gain close
|
publishing date
(GMT-12:00) International Date Line West
(GMT-11:00) American Samoa
(GMT-11:00) Midway Island
(GMT-10:00) Hawaii
(GMT-09:00) Alaska
(GMT-08:00) Pacific Time (US & Canada)
(GMT-08:00) Tijuana
(GMT-07:00) Arizona
(GMT-07:00) Chihuahua
(GMT-07:00) Mazatlan
(GMT-07:00) Mountain Time (US & Canada)
(GMT-06:00) Central America
(GMT-06:00) Central Time (US & Canada)
(GMT-06:00) Guadalajara
(GMT-06:00) Mexico City
(GMT-06:00) Monterrey
(GMT-06:00) Saskatchewan
(GMT-05:00) Bogota
(GMT-05:00) Eastern Time (US & Canada)
(GMT-05:00) Indiana (East)
(GMT-05:00) Lima
(GMT-05:00) Quito
(GMT-04:00) Atlantic Time (Canada)
(GMT-04:00) Caracas
(GMT-04:00) Georgetown
(GMT-04:00) La Paz
(GMT-04:00) Puerto Rico
(GMT-04:00) Santiago
(GMT-03:30) Newfoundland
(GMT-03:00) Brasilia
(GMT-03:00) Buenos Aires
(GMT-03:00) Greenland
(GMT-03:00) Montevideo
(GMT-02:00) Mid-Atlantic
(GMT-01:00) Azores
(GMT-01:00) Cape Verde Is.
(GMT+00:00) Casablanca
(GMT+00:00) Dublin
(GMT+00:00) Edinburgh
(GMT+00:00) Lisbon
(GMT+00:00) London
(GMT+00:00) Monrovia
(GMT+00:00) UTC
(GMT+01:00) Amsterdam
(GMT+01:00) Belgrade
(GMT+01:00) Berlin
(GMT+01:00) Bern
(GMT+01:00) Bratislava
(GMT+01:00) Brussels
(GMT+01:00) Budapest
(GMT+01:00) Copenhagen
(GMT+01:00) Ljubljana
(GMT+01:00) Madrid
(GMT+01:00) Paris
(GMT+01:00) Prague
(GMT+01:00) Rome
(GMT+01:00) Sarajevo
(GMT+01:00) Skopje
(GMT+01:00) Stockholm
(GMT+01:00) Vienna
(GMT+01:00) Warsaw
(GMT+01:00) West Central Africa
(GMT+01:00) Zagreb
(GMT+01:00) Zurich
(GMT+02:00) Athens
(GMT+02:00) Bucharest
(GMT+02:00) Cairo
(GMT+02:00) Harare
(GMT+02:00) Helsinki
(GMT+02:00) Jerusalem
(GMT+02:00) Kaliningrad
(GMT+02:00) Kyiv
(GMT+02:00) Pretoria
(GMT+02:00) Riga
(GMT+02:00) Sofia
(GMT+02:00) Tallinn
(GMT+02:00) Vilnius
(GMT+03:00) Baghdad
(GMT+03:00) Istanbul
(GMT+03:00) Kuwait
(GMT+03:00) Minsk
(GMT+03:00) Moscow
(GMT+03:00) Nairobi
(GMT+03:00) Riyadh
(GMT+03:00) St. Petersburg
(GMT+03:30) Tehran
(GMT+04:00) Abu Dhabi
(GMT+04:00) Baku
(GMT+04:00) Muscat
(GMT+04:00) Samara
(GMT+04:00) Tbilisi
(GMT+04:00) Volgograd
(GMT+04:00) Yerevan
(GMT+04:30) Kabul
(GMT+05:00) Ekaterinburg
(GMT+05:00) Islamabad
(GMT+05:00) Karachi
(GMT+05:00) Tashkent
(GMT+05:30) Chennai
(GMT+05:30) Kolkata
(GMT+05:30) Mumbai
(GMT+05:30) New Delhi
(GMT+05:30) Sri Jayawardenepura
(GMT+05:45) Kathmandu
(GMT+06:00) Almaty
(GMT+06:00) Astana
(GMT+06:00) Dhaka
(GMT+06:00) Urumqi
(GMT+06:30) Rangoon
(GMT+07:00) Bangkok
(GMT+07:00) Hanoi
(GMT+07:00) Jakarta
(GMT+07:00) Krasnoyarsk
(GMT+07:00) Novosibirsk
(GMT+08:00) Beijing
(GMT+08:00) Chongqing
(GMT+08:00) Hong Kong
(GMT+08:00) Irkutsk
(GMT+08:00) Kuala Lumpur
(GMT+08:00) Perth
(GMT+08:00) Singapore
(GMT+08:00) Taipei
(GMT+08:00) Ulaanbaatar
(GMT+09:00) Osaka
(GMT+09:00) Sapporo
(GMT+09:00) Seoul
(GMT+09:00) Tokyo
(GMT+09:00) Yakutsk
(GMT+09:30) Adelaide
(GMT+09:30) Darwin
(GMT+10:00) Brisbane
(GMT+10:00) Canberra
(GMT+10:00) Guam
(GMT+10:00) Hobart
(GMT+10:00) Melbourne
(GMT+10:00) Port Moresby
(GMT+10:00) Sydney
(GMT+10:00) Vladivostok
(GMT+11:00) Magadan
(GMT+11:00) New Caledonia
(GMT+11:00) Solomon Is.
(GMT+11:00) Srednekolymsk
(GMT+12:00) Auckland
(GMT+12:00) Fiji
(GMT+12:00) Kamchatka
(GMT+12:00) Marshall Is.
(GMT+12:00) Wellington
(GMT+12:45) Chatham Is.
(GMT+13:00) Nuku'alofa
(GMT+13:00) Samoa
(GMT+13:00) Tokelau Is.
tags :
Cancer
crawled date :
2021 - 10 - 01
save search
Global Cancer Biologics Market on Track to Reach $143.0 billion by 2026
Published:
2021-10-01
(Crawled : 16:00)
- prnewswire.com
AMGN
|
News
|
$273.69
0.66%
0.65%
2.5M
|
Health Technology
|
27.87%
|
O:
0.28%
H:
0.0%
C:
0.0%
cancer
Aravive to Present New Preliminary Data from Phase 1b Trial Evaluating AVB-500 in Clear Cell Renal Cell Carcinoma at 2021 Society for Immunotherapy of Cancer Annual Meeting
Published:
2021-10-01
(Crawled : 15:00)
- biospace.com/
ARAV
|
$0.0401
4.74%
4M
|
Health Technology
|
-98.76%
|
O:
1.34%
H:
1.86%
C:
-2.39%
immunotherapy
phase 1
renal
therapy
cancer
trial
phase 1b
phase 2b
cell carcinoma
CRISPR Therapeutics to Present Preclinical Data at the Society for Immunotherapy of Cancer (SITC) 36th Annual Meeting
Published:
2021-10-01
(Crawled : 14:15)
- biospace.com/
CRSP
|
News
M
|
$56.46
1.44%
1.42%
1.2M
|
Health Technology
|
-50.27%
|
O:
-0.16%
H:
0.57%
C:
-0.41%
crispr
immunotherapy
therapy
cancer
preclinical
pre-clinical
Oncorus to Present Initial Data from its Ongoing Phase 1 Clinical Trial of ONCR-177 at the Upcoming Society for Immunotherapy of Cancer’s (SITC) 36th Annual Meeting
Published:
2021-10-01
(Crawled : 14:15)
- biospace.com/
ONCR
|
$0.126
-75.95%
140K
|
Health Technology
|
-98.61%
|
O:
-0.11%
H:
1.61%
C:
0.21%
immunotherapy
ongoing
phase 1
therapy
cancer
trial
ALX Oncology Announces Four Abstracts Accepted for Presentation at the Society for Immunotherapy of Cancer (SITC) 36th Annual Meeting
Published:
2021-10-01
(Crawled : 14:15)
- biospace.com/
ALXO
M
|
$15.5
8.92%
8.19%
440K
|
Commercial Services
|
-80.73%
|
O:
-0.31%
H:
1.71%
C:
1.05%
presentation
immunotherapy
therapy
cancer
Atreca Announces Poster Presentations at the Society for Immunotherapy of Cancer (SITC) Annual Meeting
Published:
2021-10-01
(Crawled : 14:15)
- biospace.com/
BCEL
P
|
$0.085
0.0%
670K
|
Health Technology
|
-98.56%
|
O:
-1.12%
H:
2.11%
C:
-0.65%
presentation
immunotherapy
therapy
cancer
Tempest Announces Presentation at the Society for Immunotherapy of Cancer (SITC) 36th Annual Meeting
Published:
2021-10-01
(Crawled : 14:15)
- biospace.com/
TPST
|
$3.425
5.71%
5.4%
400K
|
Manufacturing
|
-77.61%
|
O:
0.48%
H:
4.59%
C:
3.85%
presentation
immunotherapy
pest
therapy
cancer
Actinium Announces Two Abstracts Highlighting Combinations of CD47 Targeting Immunotherapy with Targeted Radiotherapies in Solid Tumors and Blood Cancers Accepted for Presentation at Society for Immunotherapy for Cancer (SITC) Conference
Published:
2021-10-01
(Crawled : 14:00)
- biospace.com/
ATNM
|
$6.96
-2.93%
-1.14%
190K
|
Health Technology
|
-19.07%
|
O:
-0.45%
H:
1.47%
C:
-2.72%
presentation
immunotherapy
blood
solid tumors
therapy
cancer
iot
conference
NextCure to Give Three Presentations at Society for Immunotherapy of Cancer Annual Meeting
Published:
2021-10-01
(Crawled : 14:00)
- biospace.com/
NXTC
|
$1.53
-4.97%
-5.23%
90K
|
Health Technology
|
-76.11%
|
O:
3.86%
H:
11.57%
C:
8.0%
presentation
immunotherapy
therapy
cancer
Potential Response Predictors to IMV’s Lead Compound in the DeCidE Clinical Study in Patients with Advanced, Recurrent Ovarian Cancer to be Presented at SITC Annual Meeting
Published:
2021-10-01
(Crawled : 14:00)
- biospace.com/
IMV
|
$0.8225
-2.74%
45K
|
Health Technology
|
-50.45%
|
O:
1.2%
H:
2.98%
C:
1.79%
potential
cancer
ovarian cancer
Iovance Biotherapeutics to Present Clinical Data for Tumor Infiltrating Lymphocyte (TIL) Cell Therapies Across Multiple Solid Tumors and Treatment Settings at the Society for Immunotherapy of Cancer’s (SITC) 36th Annual Meeting
Published:
2021-10-01
(Crawled : 14:00)
- biospace.com/
IOVA
M
|
$11.86
4.77%
4.55%
3.9M
|
Health Technology
|
-54.1%
|
O:
-0.69%
H:
9.02%
C:
7.59%
treatment
immunotherapy
solid tumors
therapy
cancer
iot
Tanger Outlets Continues the Fight Against Breast Cancer with Tanger Pink 2021
Published:
2021-10-01
(Crawled : 14:00)
- prnewswire.com
SKT
|
$28.5
2.81%
0.0%
660K
|
Finance
|
70.06%
|
O:
1.29%
H:
3.24%
C:
1.88%
cancer
breast cancer
Shattuck Labs to Present Clinical Data on SL-172154 and SL-279252 and Preclinical Data on SL-9258 at the 2021 Society for Immunotherapy of Cancer (SITC) Annual Meeting
Published:
2021-10-01
(Crawled : 14:00)
- globenewswire.com
STTK
|
$9.47
1.83%
1.8%
320K
|
Health Technology
|
-54.37%
|
O:
0.05%
H:
5.05%
C:
3.38%
immunotherapy
therapy
cancer
preclinical
pre-clinical
Salarius Pharmaceuticals and Nationwide Children’s Hospital Announce Poster Presentation at the 2021 AACR-NCI-EORTC Virtual International Conference on Molecular Targets and Cancer Therapeutics
Published:
2021-10-01
(Crawled : 13:15)
- salariuspharma.com
SLRX
|
$0.5118
1.18%
16K
|
Commercial Services
|
-50.0%
|
O:
-0.98%
H:
1.97%
C:
-3.96%
presentation
molecular
cancer
children
conference
Anixa Biosciences Announces Notice of Allowance for Additional Patent on its CAR-T Cancer Therapy
Published:
2021-10-01
(Crawled : 13:00)
- biospace.com/
ANIX
|
$3.06
1.66%
1.63%
73K
|
Health Technology
|
-36.9%
|
O:
2.52%
H:
0.0%
C:
-2.86%
therapy
car-t
cancer
patent
bioscience
Ikena Oncology to Present a Trial-in-Progress Update, Translational Data, and Indication Selection Methodology for Novel AHR Inhibition Program at the 2021 Society for Immunotherapy of Cancer (SITC) 36th Annual Meeting
Published:
2021-10-01
(Crawled : 13:00)
- biospace.com/
IKNA
|
$1.38
6.15%
5.8%
260K
|
Manufacturing
|
-89.7%
|
O:
1.19%
H:
4.54%
C:
1.64%
immunotherapy
therapy
cancer
trial
Poseida Therapeutics to Present at Society for Immunotherapy of Cancer 2021 Annual Meeting
Published:
2021-10-01
(Crawled : 12:15)
- prnewswire.com
PSTX
|
$2.15
-0.23%
-0.23%
420K
|
Health Technology
|
-70.51%
|
O:
-0.69%
H:
0.0%
C:
-2.62%
immunotherapy
therapy
cancer
Celyad Oncology to Present New Data on Allogeneic CAR T Therapy Program at the Society for Immunotherapy of Cancer Annual Meeting
Published:
2021-10-01
(Crawled : 12:15)
- celyad.com
CYAD
|
$0.47
-12.49%
49K
|
Health Technology
|
-88.54%
|
O:
3.66%
H:
0.0%
C:
-4.47%
immunotherapy
therapy
cancer
car-t
Genmab Announces Abstracts Evaluating Investigational Solid Tumor Therapies to be Presented at the Society for Immunotherapy of Cancer’s 36th Annual Meeting (SITC 2021)
Published:
2021-10-01
(Crawled : 12:15)
- globenewswire.com
GNMSF
|
News
|
$289.67
3.83%
5.3K
|
Health Technology
|
-31.53%
|
O:
3.86%
H:
0.57%
C:
0.57%
GMAB
|
News
|
$28.54
-1.48%
-1.51%
560K
|
Health Technology
|
-33.71%
|
O:
-1.01%
H:
0.42%
C:
-0.23%
BNTX
|
News
|
$88.53
0.59%
0.59%
360K
|
Health Technology
|
-67.76%
|
O:
-8.06%
H:
3.28%
C:
1.51%
immunotherapy
therapy
cancer
solid tumors
aTyr Pharma Announces Poster Presentation at the Society for Immunotherapy of Cancer Annual Meeting
Published:
2021-10-01
(Crawled : 12:15)
- globenewswire.com
LIFE
|
$1.62
-1.22%
-1.23%
220K
|
Health Technology
|
-81.94%
|
O:
-0.55%
H:
0.74%
C:
-5.2%
presentation
immunotherapy
therapy
cancer
pharma
← Previous
1
2
Next →
Gainers vs Losers
78%
22%
Top 10 Gainers
MTTR
|
News
4
|
$4.6
164.37%
62.17%
28M
|
AGBA
|
$2.94
135.2%
57.48%
66M
|
Finance
EDBL
|
News
|
$6.46
71.81%
41.8%
2M
|
MTC
|
$2.25
44.23%
30.67%
6M
|
Technology Services
OPRT
|
News
|
$3.175
41.11%
29.13%
12M
|
Finance
SHIM
|
$3.05
35.56%
26.23%
1.1M
|
HKIT
|
$1.345
31.86%
24.16%
390K
|
Technology Services
ABVC
|
$1.36
30.77%
23.53%
7.4M
|
Wholesale Trade
OST
|
$0.512
28.0%
21.88%
290K
|
POET
|
$1.59
27.2%
21.38%
4.2M
|
Manufacturing
Your saved searches
Save your searches and get alerts when important news are released.